Axsome Therapeutics, Inc. Profile Avatar - Palmy Investing

Axsome Therapeutics, Inc.

Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of majo…
Biotechnology
US, New York [HQ]
AXSM/Financials
Segments · Problems · Premarket · Compliance

Segment Analysis

Segment Analysis
Revenue · By Business Segment
Not available for AXSM
Revenue · By Area
Not available for AXSM
End of AXSM's Analysis
CIK: 1579428 CUSIP: 05464T104 ISIN: US05464T1043 LEI: - UEI: -
Secondary Listings
AXSM has no secondary listings inside our databases.